Mohamed Ahmed Tarek (@mo_tarekneuro) 's Twitter Profile
Mohamed Ahmed Tarek

@mo_tarekneuro

Clinical Stroke fellow @McMasterStroke Previous Neuroendovascular & StrokeNet fellow @nih @EmoryUniversity.
MD, MSc, FEBN @UEMS_Neurology
#EGYPT🇪🇬❤️

ID: 1659658016088530947

calendar_today19-05-2023 20:31:27

291 Tweet

627 Followers

2,2K Following

Shadi Yaghi (@shadiyaghi2) 's Twitter Profile Photo

1. Evidence of a carotid ring sign which is enhancement of the vessel wall suggesting an acute cervical carotid occlusion. Images below show it in red arrows. ahajournals.org/doi/10.1161/ST….

1. Evidence of a carotid ring sign which is enhancement of the vessel wall suggesting an acute cervical carotid occlusion. Images below show it in red arrows. 

ahajournals.org/doi/10.1161/ST….
Jae Song (@jsongmd) 's Twitter Profile Photo

📣Do more CTA than MR carotid imaging? Need a way to classify carotid plaque using Plaque-RADS on CTA? Read our work evaluating patients w/ ESUS🧠using CTA-based Carotid Plaque-RADS! Stroke AHA/ASA AHA Science Luca Saba Penn Radiology University of Pennsylvania Neurology 📖doi.org/10.1161/STROKE…

International Journal of Stroke (@intjstroke) 's Twitter Profile Photo

Just Accepted! 💊🧠ASTRO DE study shows favorable hemo-stasis and minimal mean hematoma volume growth in patients with ICH associated with apixa-ban or rivaroxaban treatment Read more here👇 journals.sagepub.com/doi/abs/10.117…

Just Accepted!
💊🧠ASTRO DE study shows favorable hemo-stasis and minimal mean hematoma volume growth in patients with ICH associated with apixa-ban or rivaroxaban treatment

Read more here👇
journals.sagepub.com/doi/abs/10.117…
Interventional Neuroradiology (@inr_wfitn) 's Twitter Profile Photo

Can anatomical or technical factors favor reperfusion in thrombectomy? A study found clot burden score ≥8 & angle of device-clot interaction were key for FPE, with no added benefit of combining SR & aspiration. Mohamed Ahmed Tarek Mateus Damiani Monteiro Diogo Haussen journals.sagepub.com/doi/10.1177/15…

SNIS Info (@snisinfo) 's Twitter Profile Photo

A special #SNISInsights webinar "Distal Medium Vessel Thrombectomy: Recent Trial Updates and Future Directions" is this Wednesday, 2/12 at 4pm ET. Register: register.gotowebinar.com/register/89348…

A special #SNISInsights webinar "Distal Medium Vessel Thrombectomy: Recent Trial Updates and Future Directions" is this Wednesday, 2/12 at 4pm ET. 
Register: register.gotowebinar.com/register/89348…
YNIS Committee (@yniscommittee) 's Twitter Profile Photo

🧠Can't keep track of all the key #Neuroendovascular trials? We've got you covered! 🔍Check out this curated list of some landmark studies from the YNIS Education Committee snisonline.org/wp-content/upl… SNIS Info YoungNIR CV Section #MedEd #NeuroTwitter #Stroke #Endovascular

🧠Can't keep track of all the key #Neuroendovascular trials? We've got you covered!
🔍Check out this curated list of some landmark studies from the YNIS Education Committee

snisonline.org/wp-content/upl…

<a href="/SNISinfo/">SNIS Info</a> <a href="/YoungNIR/">YoungNIR</a> <a href="/cvsection/">CV Section</a> #MedEd #NeuroTwitter #Stroke #Endovascular
Shadi Yaghi (@shadiyaghi2) 's Twitter Profile Photo

Not all hypodensity/ASPECTS is the same in large core. In SELECT-2, if ≥26 mL of brain tissue has ≤26 HU (severe hypodensity), there may be no benefit from EVT in large core patients & increased complications Thanh Nguyen 🇺🇦 Amrou Sarraj Stroke AHA/ASA ahajournals.org/doi/full/10.11…

Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

BREAKING from NEJM In cancer patients w/ Cancer-Associated Venous Thromboembolism, reduced-dose apixaban (2.5 mg BID) is : 🔘Noninferior to full-dose (5 mg BID) for VTE recurrence 🔘Lower bleeding risk (12.1% vs. 15.6%) 🔘Safer extended anticoagulation, same protection.

BREAKING from <a href="/NEJM/">NEJM</a> 
In cancer patients w/ Cancer-Associated Venous Thromboembolism, reduced-dose apixaban (2.5 mg BID) is :
🔘Noninferior to full-dose (5 mg BID) for VTE recurrence
🔘Lower bleeding risk (12.1% vs. 15.6%)
🔘Safer extended anticoagulation, same protection.
Abdulla A. Damluji, MD, PhD (@drdamluji) 's Twitter Profile Photo

Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a): NEJM #ACC25 🥸This is a great trial 😱 Let's summarize 👇👇👇

Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a): <a href="/NEJM/">NEJM</a> #ACC25 

🥸This is a great trial 

😱 Let's summarize 

👇👇👇
Shikha Jha M.D.🫀 (@shikha_cardio) 's Twitter Profile Photo

ACC 2025 LATE BREAKING CLINICAL TRIALS - One LINER SUMMARY 📸 AT A GLANCE ⭐️ What a phenomenal scientific meeting! Congratulations to all the presenters &research leaders for yet another fantastic year of innovation & research. 🫀❤️ 😊 #ACC2025 American College of Cardiology UW-Madison Division of Cardiovascular Medicine CardioNerds

ACC 2025  LATE BREAKING CLINICAL TRIALS - One LINER SUMMARY 📸 AT A GLANCE ⭐️ What a phenomenal scientific meeting! Congratulations to all the presenters &amp;research leaders for yet another fantastic year of innovation &amp; research. 🫀❤️ 😊 #ACC2025 <a href="/ACCinTouch/">American College of Cardiology</a> <a href="/uw_cvm/">UW-Madison Division of Cardiovascular Medicine</a> <a href="/CardioNerds/">CardioNerds</a>
SVIN (@svinsociety) 's Twitter Profile Photo

🔔 Reminder: Registration is Open! Don’t miss the upcoming Virtual Stroke Academy Grand Rounds Lecture on April 22 featuring Dr. Diogo Haussen presenting on Carotid Web. Register now: zurl.co/c3OXM #SVIN #SVINGrandRounds #SVINVSA

🔔 Reminder: Registration is Open! Don’t miss the upcoming Virtual Stroke Academy Grand Rounds Lecture on April 22 featuring Dr. Diogo Haussen presenting on Carotid Web.

Register now: zurl.co/c3OXM 

#SVIN #SVINGrandRounds #SVINVSA
ESNR (@esnrad) 's Twitter Profile Photo

ESNR-EAN Joint Webinar: Amyloid related imaging abnormalities (ARIA): from trial to clinical practice Event page: buff.ly/po9eJeG Free registration link: buff.ly/RiawzPD

ESNR-EAN Joint Webinar: Amyloid related imaging abnormalities (ARIA): from trial to clinical practice
Event page: buff.ly/po9eJeG
Free registration link: buff.ly/RiawzPD
ESNR (@esnrad) 's Twitter Profile Photo

ESNR Neurointervention Webinar Series Volume 16: “Glymphatics and Veins: The Next Neurointerventional Frontier” Date: 17 June 2025 Time: 18:00-19:00 CEST Event page: buff.ly/ZITFaPq Free registration link: buff.ly/roDAAOT

ESNR Neurointervention Webinar Series Volume 16: “Glymphatics and Veins: The Next Neurointerventional Frontier”
Date: 17 June 2025
Time: 18:00-19:00 CEST
Event page: buff.ly/ZITFaPq
Free registration link: buff.ly/roDAAOT
Shadi Yaghi (@shadiyaghi2) 's Twitter Profile Photo

Every 10 mg/dL ⬇️ in LDL for patients with ICAD stroke has 9% ⬇️ rates of recurrent stroke or MI. this theoretical framework suggests that PCSK9i can help achieve this. We need PCSK-9i trials in ICAD Jim Siegler (@jimsieglermd.bsky.social now) Tareq Kass-Hout Malik Ghannam Seemant Chaturvedi neurology.org/doi/10.1212/WN…

Mohamed Ahmed Tarek (@mo_tarekneuro) 's Twitter Profile Photo

Alhamdulillah – I am deeply grateful to Allah for granting me the strength, patience, and perseverance to complete my stroke fellowship. A heartfelt thank you to my family, my mentors, and my colleagues who guided, supported, and inspired me during this year❤️❤️. McMaster Stroke Program

Alhamdulillah – I am deeply grateful to Allah for granting me the strength, patience, and perseverance to complete my stroke fellowship. 
A heartfelt thank you to my family, my mentors, and my colleagues who guided, supported, and inspired me during this year❤️❤️. <a href="/McmasterStroke/">McMaster Stroke Program</a>